Specific Modified Exercise Program for Patients Having Chronic Asthma

NCT06197737 | Completed DMC

• 1 other identifier: REC/MS-PT/01379
• Study Type: interventional
• Target: 78
• Locations: 1 country
• Sites: 1

Brief Summary

To compare the effects of moderate intensity interval training and sprint interval training on patients having chronic asthma.

Conditions

Asthma

Outcome Measures

Primary Outcomes (5)

• Assessment of change in the Inspiratory Capacity

  It will measured using an incentive spirometer

  Baseline, 8th week and then 16th week

• Assessment of change in the Pulmonary Function

  Electronic spirometer will be used to measure all the parameters of pulmonary function.

  Baseline, 8th week and then 16th week

• Assessment of change in the Oxygen saturation

  Measured using pulse oximeter before, during and after the intervention.

  Baseline, 8th week and then 16th week

• Assessment of change in the Rate of perceived exertion / dyspnea

  measured through borg scale during the assigned intervention

  Baseline, 8th week and then 16th week

• Assessment of change in the cardiovascular endurance

  PACER test for cardiovascular endurance test

  Baseline, 8th week and then 16th week

Study Arms (3)

Moderate Intensity Interval Training

EXPERIMENTAL

These participants will perform moderate intensity interval training. The intervention will be applied thrice a week. Moderate intensity interval training in which they do stair climbing 3 times a week And for every 1 interval I will ask them to take rest for 3 minutes.

Other: Moderate Intensity Interval Training

Sprint Interval Training

EXPERIMENTAL

These participants will perform sprint interval training and frequency will be 3 days a week. The participants will perform sprint interval training in which they will do stair climbing 3 times a week with a fast pace.

Other: Sprint Interval Training

pharmacological treatment

OTHER

They will be on pharmacological treatment as prescribed by their pulmonologist.

Other: pharmacological treatment

Interventions

Moderate Intensity Interval Training OTHER

Participants in this group will perform moderate intensity interval training in which they will perform stair climbing 3 times a week and for every 1 interval I will ask them to take rest for 3 minutes.

Moderate Intensity Interval Training

Sprint Interval Training OTHER

sprint interval training in which they will do stair climbing 3 times a week with a fast pace.

Sprint Interval Training

pharmacological treatment OTHER

They will be on pharmacological treatment as prescribed by their pulmonologist.

pharmacological treatment

Eligibility Criteria

• Age: 15 Years - 25 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64)

You may qualify if:

• Patients having chronic asthma
• Age between 15-25 years.
• Participants having no dyspnea at rest .
• Participants scoring 13 or less on borg scale

You may not qualify if:

• History of co-morbidities.
• History of recent fractures.
• Participants scoring greater than 13 on BORG scale
• Exercise induced asthma (evaluated through BRUCE protocol).
• Individuals with co-morbidities related to any neurological, cardiovascular, psychological and musculoskeletal disorders .
• Patients score falling 15 or more on Borg scale.

Sponsors & Collaborators

• Riphah International University: lead

Study Sites (1)

Abasyn University

Islamabad, Federal Capital, 46000, Pakistan

Location

MeSH Terms

Conditions

Asthma

Interventions

High-Intensity Interval Training; Drug Therapy

Condition Hierarchy (Ancestors)

Bronchial Diseases; Respiratory Tract Diseases; Lung Diseases, Obstructive; Lung Diseases; Respiratory Hypersensitivity; Hypersensitivity, Immediate; Hypersensitivity; Immune System Diseases

Intervention Hierarchy (Ancestors)

Physical Conditioning, Human; Exercise; Motor Activity; Movement; Musculoskeletal Physiological Phenomena; Musculoskeletal and Neural Physiological Phenomena; Therapeutics

Study Officials

• Malik Muhammad Ali Awan, MSPT

  Riphah International University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: May 4, 2023
• First Posted: January 9, 2024
• Study Start: March 1, 2023
• Primary Completion: January 1, 2024
• Study Completion: January 1, 2024
• Last Updated: May 21, 2024

Record last verified: 2024-05

Data Sharing

• IPD Sharing: Will not share

Locations

PA (1)